{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:17:12Z","timestamp":1778771832195,"version":"3.51.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Histiocytic sarcoma (HS) is an aggressive neoplasm in dogs, and in most instances, the disease is localized, but not amenable to surgical removal, or is disseminated. Affected patients usually die within 6 months. There have been no prospective studies to determine efficacy of single-agent chemotherapy in dogs with HS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Single-agent CCNU [1-(2-chloroethyl)3-cyclohexyl-1-nitrosourea; lomustine] has antitumor activity against HS in dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-one dogs with histologically confirmed, nonresectable localized or disseminated HS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective, open-label phase II clinical trial in which dogs with previously untreated HS were uniformly treated with CCNU as a single oral dosage of 90\u2003mg\/m2 every 4 weeks. The primary outcome measure was reduction in tumor size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen dogs with disseminated HS and 7 with localized HS were enrolled between 1999 and 2008. Overall response rate was 29% (95% confidence interval [CI], 14\u201350%) for a median of 96 days (95% CI, 55\u2013137 days). Three dogs (1 disseminated, 2 localized) had complete responses lasting for 54\u2013269 days and 3 dogs (2 disseminated, 1 localized) had partial responses lasting for 78\u2013112 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>CCNU, when used as a single agent, has activity against HS in dogs. Evaluation of CCNU postoperatively for dogs with resectable localized HS and as part of combination therapy for tumors that are nonresectable or disseminated should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2010.0588.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T15:06:10Z","timestamp":1284476770000},"page":"1528-1531","source":"Crossref","is-referenced-by-count":64,"title":["Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma"],"prefix":"10.1093","volume":"24","author":[{"given":"K.M.","family":"Rassnick","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"},{"name":"Harrington Oncology Program, Cummings School of Veterinary Medicine, Tufts University , North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Moore","sequence":"additional","affiliation":[{"name":"Harrington Oncology Program, Cummings School of Veterinary Medicine, Tufts University , North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Russell","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Biomedical Sciences, , Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.C.","family":"Northrup","sequence":"additional","affiliation":[{"name":"Harrington Oncology Program, Cummings School of Veterinary Medicine, Tufts University , North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kristal","sequence":"additional","affiliation":[{"name":"Harrington Oncology Program, Cummings School of Veterinary Medicine, Tufts University , North Grafton, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Bailey","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Flory","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Kiselow","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Intile","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"2026020303175059800_b1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1354\/vp.39-1-74","article-title":"Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs","volume":"39","author":"Affolter","year":"2002","journal-title":"Vet Pathol"},{"issue":"6","key":"2026020303175059800_b2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/jhered\/esp039","article-title":"Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese Mountain Dog breed","volume":"100","author":"Abadie","year":"2009","journal-title":"J Hered"},{"key":"2026020303175059800_b3","first-page":"512","article-title":"The diagnosis and prognosis of synovial tumors in dogs","volume":"38","author":"Craig","year":"2002","journal-title":"35 cases"},{"key":"2026020303175059800_b4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002800050591","article-title":"Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors","volume":"39","author":"Vail","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026020303175059800_b5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1292\/jvms.55.1059","article-title":"Malignant histiocytosis with multiple skin lesions in a dog","volume":"55","author":"Uno","year":"1993","journal-title":"J Vet Med Sci"},{"key":"2026020303175059800_b6","first-page":"1789","article-title":"Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104","volume":"3","author":"Visonneau","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2026020303175059800_b7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"Skorupski","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020303175059800_b8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","article-title":"The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapy agent","volume":"13","author":"Gehan","year":"1961","journal-title":"J Chron Dis"},{"key":"2026020303175059800_b9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5829.2009.00186.x","article-title":"Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy","volume":"7","author":"Skorupski","year":"2009","journal-title":"Vet Comp Oncol"},{"key":"2026020303175059800_b10","first-page":"63","article-title":"Histiocytic sarcomas in flat-coated retrievers","volume":"4","author":"Fidel","year":"2006","journal-title":"A summary of 37 cases (November 1998-March 2005)"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2010.0588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/6\/1528\/66654206\/j.1939-1676.2010.0588.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/6\/1528\/66654206\/j.1939-1676.2010.0588.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:17:58Z","timestamp":1770106678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/24\/6\/1528\/8447246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0588.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,11]]},"published":{"date-parts":[[2010,11,1]]}}}